Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 7Uterine Cervical Neoplasms 5Neoplasms 4Esophageal Neoplasms 4Brain Neoplasms 4Thyroid Neoplasms 3Neuroendocrine Tumors 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Multiple Myeloma 2Melanoma 2Lung Neoplasms 2Hematologic Neoplasms 2Glioblastoma 2Carcinoma, Transitional Cell 2Astrocytoma 2Adrenal Gland Neoplasms 2Vaginal Neoplasms 1Uveal Melanoma 1Uterine Neoplasms 1

Interventions

Radiotherapy 7Cisplatin 7Irinotecan 5Fluorouracil 5pembrolizumab 4Docetaxel 4Paclitaxel 3Oxaliplatin 3durvalumab 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Drug Therapy 2Carboplatin 2vandetanib 1toripalimab 1tislelizumab 1spartalizumab 1ribociclib 1obinutuzumab 1naptumomab estafenatox 1matuzumab 1futibatinib 1adavosertib 1Vorinostat 1Topotecan 1Taxes 1Surgical Procedures, Operative 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adenocarcinoma Of Esophagus × Fluorodeoxyglucose F18 × Clear all
NCT01561014 2018-07-02

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Wake Forest University Health Sciences

Phase 1 Completed
9 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡